Discovery, development and effectiveness of coagulation-inhibiting drugs for stroke therapy.

Monika Killer; Eugen Trinka; Jörg Kraus; Erasmia Broussalis

doi:10.1517/17460441.2011.563732

Discovery, development and effectiveness of coagulation-inhibiting drugs for stroke therapy.

Monika Killer^* (First author), Eugen Trinka (First author), Jörg Kraus (Co-author), Erasmia Broussalis (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

1 Citation (Web of Science)

Original language	English
Pages (from-to)	353-369
Journal	EXPERT OPINION ON DRUG DISCOVERY
Volume	6
Issue number	4
DOIs	https://doi.org/10.1517/17460441.2011.563732
Publication status	Published - 2011

Keywords

ACUTE ISCHEMIC-STROKE
ACUTE CORONARY SYNDROMES
TISSUE-PLASMINOGEN ACTIVATOR
DIRECT THROMBIN INHIBITOR
FACTOR XA INHIBITOR
NONVALVULAR ATRIAL-FIBRILLATION
RANDOMIZED CONTROLLED-TRIAL
PLACEBO-CONTROLLED TRIAL
ST-SEGMENT ELEVATION
SECONDARY PREVENTION

Access to Document

10.1517/17460441.2011.563732

Cite this

@article{9fdecbd3b85f41bcaef8c8b7e5689b5d,

title = "Discovery, development and effectiveness of coagulation-inhibiting drugs for stroke therapy.",

keywords = "ACUTE ISCHEMIC-STROKE, ACUTE CORONARY SYNDROMES, TISSUE-PLASMINOGEN ACTIVATOR, DIRECT THROMBIN INHIBITOR, FACTOR XA INHIBITOR, NONVALVULAR ATRIAL-FIBRILLATION, RANDOMIZED CONTROLLED-TRIAL, PLACEBO-CONTROLLED TRIAL, ST-SEGMENT ELEVATION, SECONDARY PREVENTION",

author = "Monika Killer and Eugen Trinka and J{\"o}rg Kraus and Erasmia Broussalis",

year = "2011",

doi = "10.1517/17460441.2011.563732",

language = "English",

volume = "6",

pages = "353--369",

journal = "EXPERT OPINION ON DRUG DISCOVERY",

issn = "1746-0441",

number = "4",

}

TY - JOUR

T1 - Discovery, development and effectiveness of coagulation-inhibiting drugs for stroke therapy.

AU - Killer, Monika

AU - Trinka, Eugen

AU - Kraus, Jörg

AU - Broussalis, Erasmia

PY - 2011

Y1 - 2011

KW - ACUTE ISCHEMIC-STROKE

KW - ACUTE CORONARY SYNDROMES

KW - TISSUE-PLASMINOGEN ACTIVATOR

KW - DIRECT THROMBIN INHIBITOR

KW - FACTOR XA INHIBITOR

KW - NONVALVULAR ATRIAL-FIBRILLATION

KW - RANDOMIZED CONTROLLED-TRIAL

KW - PLACEBO-CONTROLLED TRIAL

KW - ST-SEGMENT ELEVATION

KW - SECONDARY PREVENTION

U2 - 10.1517/17460441.2011.563732

DO - 10.1517/17460441.2011.563732

M3 - Review article

C2 - 22646014

SN - 1746-0441

VL - 6

SP - 353

EP - 369

JO - EXPERT OPINION ON DRUG DISCOVERY

JF - EXPERT OPINION ON DRUG DISCOVERY

IS - 4

ER -